- Home
- SSNC vs ICLR Comparison
SSNC vs ICLR Comparison
Compare SSNC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSNC
- ICLR
- Stock Information
- Founded
- SSNC 1986
- ICLR 1990
- Country
- SSNC United States
- ICLR Ireland
- Employees
- SSNC N/A
- ICLR N/A
- Industry
- SSNC EDP Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SSNC Technology
- ICLR Health Care
- Exchange
- SSNC Nasdaq
- ICLR Nasdaq
- Market Cap
- SSNC 18.8B
- ICLR 17.2B
- IPO Year
- SSNC 1996
- ICLR 1998
- Fundamental
- Price
- SSNC $78.50
- ICLR $198.11
- Analyst Decision
- SSNC Strong Buy
- ICLR Strong Buy
- Analyst Count
- SSNC 8
- ICLR 12
- Target Price
- SSNC $77.75
- ICLR $284.82
- AVG Volume (30 Days)
- SSNC 1.1M
- ICLR 903.2K
- Earning Date
- SSNC 02-06-2025
- ICLR 02-19-2025
- Dividend Yield
- SSNC 1.25%
- ICLR N/A
- EPS Growth
- SSNC 15.08
- ICLR 44.49
- EPS
- SSNC 2.79
- ICLR 8.99
- Revenue
- SSNC $5,763,900,000.00
- ICLR $8,306,823,000.00
- Revenue This Year
- SSNC $8.24
- ICLR $3.95
- Revenue Next Year
- SSNC $5.56
- ICLR $2.84
- P/E Ratio
- SSNC $28.12
- ICLR $22.04
- Revenue Growth
- SSNC 6.16
- ICLR 3.63
- 52 Week Low
- SSNC $59.53
- ICLR $183.38
- 52 Week High
- SSNC $79.59
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- SSNC 61.46
- ICLR 35.86
- Support Level
- SSNC $74.30
- ICLR $196.50
- Resistance Level
- SSNC $76.06
- ICLR $228.29
- Average True Range (ATR)
- SSNC 1.27
- ICLR 6.57
- MACD
- SSNC 0.32
- ICLR -1.36
- Stochastic Oscillator
- SSNC 79.40
- ICLR 5.06
About SSNC SS&C Technologies Holdings Inc.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual data room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.